Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT07909265
Recruiting
Prospective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 2 Nov 2026
NCT06764771
Recruiting
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Phase 1 · Australia, Canada, United States · 8 sites
Registry update: 29 Jul 2026
NCT06926374
Recruiting
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Not applicable · China · 1 site
Registry update: 16 Apr 2025
NCT06661720
Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Phase 3 · United States · 429 sites
Registry update: 3 Nov 2026
NCT06673329
Recruiting
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 · United States · 1 site
Registry update: 13 May 2026
NCT06525831
Recruiting
Rein 3D PRINT MECHANICS
Not applicable · France · 1 site
Registry update: 14 Apr 2026
NCT07590310
Recruiting
Clinical Application of CAIX-Targeted PET Imaging in Tumors
Early phase 1 · China · 1 site
Registry update: 15 May 2026
NCT06792552
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Phase 1 · China, United States · 17 sites
Registry update: 17 Aug 2026
NCT06376669
Recruiting
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 3 Apr 2026
NCT06839105
Recruiting
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Phase 1 · China · 13 sites
Registry update: 2 Jul 2026
NCT06835972
Recruiting
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1/2 · United States · 8 sites
Registry update: 22 Oct 2026
NCT06699602
Recruiting
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Phase 2 · United States · 7 sites
Registry update: 4 Mar 2026
NCT06805825
Recruiting
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Phase 1 · United States · 5 sites
Registry update: 23 Sept 2025
NCT07303725
Recruiting
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Not applicable · United States · 1 site
Registry update: 26 Dec 2025
NCT07018037
Recruiting
Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
Not applicable · Italy · 1 site
Registry update: 5 Jun 2026
NCT07175480
Recruiting
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · China · 1 site
Registry update: 16 Sept 2025
NCT06674811
Recruiting
Biomarkers of Resiliency In Childhood Cancer Surgery
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT06595329
Recruiting
Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy
Phase 1 · Croatia · 1 site
Registry update: 10 Mar 2025
NCT06750185
Recruiting
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Phase 1/2 · Australia, United States · 11 sites
Registry update: 9 Sept 2026
NCT06714916
Recruiting
Optimising Renal Tumour Management Through Artificial Intelligence Modules
Not applicable · China · 1 site
Registry update: 19 Mar 2025

Ordered by registry start date. Freshness and sponsorship never change the order.